fme proudly announces our selection by a prominent pharmaceutical company to conduct an initial migration assessment. Our role involves unifying data and documents from disparate systems, and preparing them for smooth integration into the global Veeva Vault RIM deployment. With a wealth of experience in migration evaluations for life sciences clients, fme assures the utmost in risk mitigation and value delivery. Our approach is finely tuned to align with both business and technical objectives. Reach out today to explore our comprehensive migration evaluation packages and discover how fme can streamline and de-risk your migration efforts.
fme US, LLC’s Post
More Relevant Posts
-
Watch the video featuring Piotr Wierzchowski, Business Development Manager, to delve deeper into: 💡Why the development of contemporary quality management support tools is so significant in the pharmaceutical sector. 💡 What pharma organizations should have beyond the typical QMS for managing quality or documentation management. 💡What fundamental characteristics every such system should meet. Interested in further insights on this topic? Let's arrange a call to discuss further at 📧: validation@ecvalidation.com #Quality #QualityManagement #DocumentationManagement #QMS #VeevaSystems
To view or add a comment, sign in
-
Unlock the power of data in Pharma 4.0 with the NTT DATA GxP Data Lake —a compliant and scalable cloud-based platform for pharmaceutical companies. Seamlessly gather diverse data from multiple sources to overcome business challenges and pave the way for a more data-driven future. Explore the full paper here 👉 https://bit.ly/3u6HNJi . #SAP #NTTDATA
To view or add a comment, sign in
-
How do we work with our clients? 🤔 Here's a case study from some recent work we did with a BioPharma firm. Take a look at the slides below to read about the project, the case, and the outcome from their partnership with i-Pharm GxP. _________________ Got a project to scope in? Contact us today to discuss how we can help develop your business! #iPharmGxP #BioPharma
To view or add a comment, sign in
-
Unlock the power of data in Pharma 4.0 with the #NTTDATA GxP Data Lake - a compliant and scalable cloud-based platform for pharmaceutical companies. Seamlessly gather diverse data from multiple sources to overcome business challenges and pave the way for a more data-driven future. Explore the full paper here: https://lnkd.in/e2tEmDjt #SAP
To view or add a comment, sign in
-
In this talk, an approach consisting of a digital loop is presented, leveraging ICH Q9(R1) and ICH Q13 regulatory packages, integrating process data acquisition (via Continued Process Verification plan, for example) and Quality Risk Management systems. This retrofitting digital loop, rooted within the company’s Pharmaceutical Quality System, will enable companies to dynamically refine process control strategies supported by process insights and data, which are then incorporated in a pre-defined formal structure; thus, enabling the expected formal flexibility and reducing subjectivity for quality decisions, both critical concepts for efficient CM processes and safety and efficacy of the final product. Maria Batalha Kevin Bittorf Matthew Mollan John Nadzam #INTERPHEX24
To view or add a comment, sign in
-
Thrilled to offer consulting services for facilitating the integration of Labware LIMS within pharmaceutical organizations. Leveraging our expertise, we aim to streamline laboratory operations, enhance data management capabilities, and ensure compliance with regulatory standards. Elevate your lab's efficiency with our tailored solutions. #LabwareLIMS #ConsultingServices #Pharma #DataManagement #RegulatoryCompliance #Efficiency #Innovation #HealthcareTech
To view or add a comment, sign in
-
Lions and Tigers and IRA’s, oh my! There’s no doubt that the impacts of IRA will be felt far and wide, including Kansas. And if not the IRA, perhaps copay accumulators/maximizers or how you should handle Alternative Funding Programs (AFP’s) are keeping you up at night. There’s never a better time than NOW, to ensure your Patient Support Programs are finely tuned, capable, and/or adaptable to the changes on the horizon. Take a look at the attached white paper to learn more about how EVERSANA Specialty Consulting can equip you with data driven strategies and predictive modeling tools to navigate everything from the new Medicare requirement on product wastage, adjustments to PAP FPL, and ensuring your copay program is battle tested to take on copay accumulators and maximizers. Heading to Asembia? We’ll be there too and happy to connect!
In an ever-evolving landscape, data-driven insights are paramount for success. In this latest article from John Chatas, Lee Ann Steadman and Sean Sweeny, discover how EVERSANA’s Specialty Consulting team pioneers predictive modeling solutions for pharmaceutical manufacturers with a revolutionary approach to market forecasting and regulatory compliance. Download the article: https://ow.ly/mAex50RmcMp Attending ASEMBIA 2024? Visit with our experts to learn more about how EVERSANA leverages the power of data analytics and predictive modeling to empower manufacturers to traverse the complexities of product launches, achieve their business goals and serve patients as effectively as possible. #DataAnalytics #PredictiveModeling #ASEMBIA
To view or add a comment, sign in
-
-
🔬 Ever wondered how to bridge the gap between pharmaceutical research and production? Last week, I made a post about Enterprise Recipe Management (ERM) – a real game-changer that's is currently entering the pharmaceutical industry. But how does ERM work in practice? 📈 ERM serves as the digital backbone that seamlessly connects every step of the pharmaceutical process, from lab to commercial production. It's the linchpin that unifies data, technology, and expertise. Imagine a single platform where scientists, process developers, and production engineers collaborate. ERM eradicates data silos and knowledge gaps, enabling real-time sharing of insights. This paves the way for faster technology transfer and recipe upscaling, translating into reduced time-to-market for life-changing medications. 👨🔬 #siemens #pharma #erm
To view or add a comment, sign in
-
The global pharmaceutical analytical testing outsourcing market size was valued at USD 8.3 billion in 2023 and is projected to grow at a CAGR of 8.4% from 2024 to 2030. https://lnkd.in/dttHMU2C Growth in the market can be attributed due to increasing focus toward safety, & quality; regulation, pricing benefits of outsourcing, and rising number of end use. Besides, increasing R&D investment is one of the critical sustainability strategies adopted by market players. As, not all companies have an infrastructure for analytical testing. Therefore, outsourcing these operations is a suitable option, which helps to save time and cost. Recent Developments · In December 2023, Agno Pharma acquired Lubrizol Particle Sciences Inc. The acquisition encompasses the drug product formulation technology integral to Particle Sciences Inc. including the PA, Bethlehem development & manufacturing site. · In November 2023, Eurofins acquired Quasfar supporting the pharmaceutical industry in Latin America, enhancing its capabilities in R&D, providing support in the early stages of pharmaceutical product development. #PharmaceuticalAnalyticalTesting #OutsourcingMarket #MarketResearch #Bioanalytical #PharmaceuticalCompanies #Biopharmaceuticals #ContractResearchOrganizations #IndustryTrends
Pharmaceutical Analytical Testing Outsourcing Market Report, 2030
grandviewresearch.com
To view or add a comment, sign in
-
In an ever-evolving landscape, data-driven insights are paramount for success. In this latest article from John Chatas, Lee Ann Steadman and Sean Sweeny, discover how EVERSANA’s Specialty Consulting team pioneers predictive modeling solutions for pharmaceutical manufacturers with a revolutionary approach to market forecasting and regulatory compliance. Download the article: https://ow.ly/mAex50RmcMp Attending ASEMBIA 2024? Visit with our experts to learn more about how EVERSANA leverages the power of data analytics and predictive modeling to empower manufacturers to traverse the complexities of product launches, achieve their business goals and serve patients as effectively as possible. #DataAnalytics #PredictiveModeling #ASEMBIA
To view or add a comment, sign in
-